Your browser doesn't support javascript.
loading
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP.
Driessen, Julia; Kersten, Marie José; Visser, Lydia; van den Berg, Anke; Tonino, Sanne H; Zijlstra, Josée M; Lugtenburg, Pieternella J; Morschhauser, Franck; Hutchings, Martin; Amorim, Sandy; Gastinne, Thomas; Nijland, Marcel; Zwezerijnen, Gerben J C; Boellaard, Ronald; de Vet, Henrica C W; Arens, Anne I J; Valkema, Roelf; Liu, Roberto D K; Drees, Esther E E; de Jong, Daphne; Plattel, Wouter J; Diepstra, Arjan.
Afiliación
  • Driessen J; Department of Hematology, Amsterdam UMC, University of Amsterdam, LYMMCARE, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Kersten MJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, LYMMCARE, Cancer Center Amsterdam, Amsterdam, The Netherlands. m.j.kersten@amsterdamumc.nl.
  • Visser L; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • van den Berg A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Tonino SH; Department of Hematology, Amsterdam UMC, University of Amsterdam, LYMMCARE, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Zijlstra JM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
  • Morschhauser F; Department of Hematology, Centre Hospitalier Universitaire, Lille, France.
  • Hutchings M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Amorim S; Department of Hematology, Hopital Saint Louis, Paris, France.
  • Gastinne T; Department of Hematology, Centre Hospitalier Universitaire, Nantes, France.
  • Nijland M; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Zwezerijnen GJC; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Boellaard R; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • de Vet HCW; Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
  • Arens AIJ; Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Valkema R; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Liu RDK; Department of Hematology, Amsterdam UMC, University of Amsterdam, LYMMCARE, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Drees EEE; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • de Jong D; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Plattel WJ; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. a.diepstra@umcg.nl.
Leukemia ; 36(12): 2853-2862, 2022 12.
Article en En | MEDLINE | ID: mdl-36241696
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Inmunoconjugados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos